DIADEMA PARTNERS LP
Top Portfolio Positions
110 positions ·
$569,565,326 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
87,503 | $51,887,528 | 9.11% | |
| VRTX |
Vertex Pharmaceuticals Inc / Ma
Healthcare
|
96,940 | $43,287,587 | 7.60% | |
| VKTX |
Viking Therapeutics, Inc.
Healthcare
|
1,184,381 | $38,539,757 | 6.77% | |
| CAPR |
Capricor Therapeutics, Inc.
Healthcare
|
1,031,551 | $31,359,150 | 5.51% | |
| ABVX |
Abivax S.A.
Healthcare
|
275,944 | $30,726,364 | 5.39% | |
| LQDA |
Liquidia Corp
Healthcare
|
712,100 | $26,874,654 | 4.72% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
206,372 | $20,069,677 | 3.52% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
222,500 | $18,727,825 | 3.29% | |
| INCY |
Incyte Corp
Healthcare
|
183,429 | $17,264,337 | 3.03% | |
| KOD |
Kodiak Sciences Inc.
Healthcare
|
440,062 | $16,775,163 | 2.95% |
Portfolio Trend
6 quarters · across all stocks
Holdings in SLS
4 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,269,000 | 300,000 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $1,601,873 | 424,900 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $644,000 | 400,000 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $876,000 | 400,000 | Call | Sole | 2025-08-14 | |
| No 13F history on record for this holder in this stock. | ||||||